- Home
- IMMX vs CEV Comparison
IMMX vs CEV Comparison
Compare IMMX & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- CEV
- Stock Information
- Founded
- IMMX 2014
- CEV 1999
- Country
- IMMX United States
- CEV United States
- Employees
- IMMX N/A
- CEV N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- CEV Finance/Investors Services
- Sector
- IMMX Health Care
- CEV Finance
- Exchange
- IMMX Nasdaq
- CEV Nasdaq
- Market Cap
- IMMX 65.5M
- CEV 66.8M
- IPO Year
- IMMX 2021
- CEV N/A
- Fundamental
- Price
- IMMX $2.10
- CEV $9.91
- Analyst Decision
- IMMX Strong Buy
- CEV
- Analyst Count
- IMMX 1
- CEV 0
- Target Price
- IMMX $8.00
- CEV N/A
- AVG Volume (30 Days)
- IMMX 181.7K
- CEV 19.6K
- Earning Date
- IMMX 11-11-2025
- CEV 01-01-0001
- Dividend Yield
- IMMX N/A
- CEV 4.23%
- EPS Growth
- IMMX N/A
- CEV N/A
- EPS
- IMMX N/A
- CEV 0.36
- Revenue
- IMMX N/A
- CEV N/A
- Revenue This Year
- IMMX N/A
- CEV N/A
- Revenue Next Year
- IMMX N/A
- CEV N/A
- P/E Ratio
- IMMX N/A
- CEV $29.36
- Revenue Growth
- IMMX N/A
- CEV N/A
- 52 Week Low
- IMMX $1.26
- CEV $8.83
- 52 Week High
- IMMX $3.20
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- IMMX 42.26
- CEV 74.13
- Support Level
- IMMX $2.09
- CEV $9.45
- Resistance Level
- IMMX $2.34
- CEV $10.01
- Average True Range (ATR)
- IMMX 0.16
- CEV 0.06
- MACD
- IMMX 0.01
- CEV 0.05
- Stochastic Oscillator
- IMMX 35.90
- CEV 81.58
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.